The Readout

The Readout April 24, 2025

Tariff questions swirl around pharma earnings

Adam's Take

Adam's Take April 24, 2025

STAT Plus: Biotech is back, baby! It’s all upside from here

advertisement

The Readout

The Readout April 23, 2025

CRISPR’s CEO got a big payday

Biotech

Biotech April 22, 2025

STAT Plus: Bristol’s Cobenfy disappoints as supplemental antipsychotic drug

D.C. Diagnosis

D.C. Diagnosis April 22, 2025

STAT Plus: Research grants as political ammo; Death to dyes?